Susquehanna Fundamental Investments’s GoodRx Holdings GDRX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-172,840	Closed	-$762K	–	844
2025 Q1	$762K	Buy	+172,840	New	+$811K	0.01%	752
2024 Q2	$443K	Sell	56,776 -8,900	-14%	-$65.9K	0.01%	720
2024 Q1	$466K	Buy	+65,676	New	+$434K	0.02%	477
2023 Q1	–	Sell	-104,256	Closed	-$486K	–	1006
2022 Q4	$486K	Sell	104,256 -209,523	-67%	-$1.03M	0.01%	874
2022 Q3	$1.47M	Buy	+313,779	New	+$1.98M	0.02%	680
2022 Q1	$7.35M	Buy	380,259 +249,579	+191%	+$5.72M	0.14%	200
2021 Q4	$4.27M	Buy	130,680 +98,100	+301%	+$3.95M	0.11%	235
2021 Q3	$1.34M	Buy	+32,580	New	+$1.18M	0.02%	747

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Susquehanna Fundamental Investments's GDRX Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 172,840 shares — an estimated $762K sold.

Susquehanna Fundamental Investments first reported a position in GDRX in Q3 2021 and held it in 8 quarters. The position peaked at $7.35M in Q1 2022. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 172,840 GoodRx Holdings shares in Q2 2025, an estimated $762K.
Susquehanna Fundamental Investments first reported a position in GoodRx Holdings in Q3 2021 and held it in 8 quarters.
Susquehanna Fundamental Investments's GoodRx Holdings position peaked at $7.35M in Q1 2022.
182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.